• 1
    Ohashi K, Murakami Y, Maruyama M, Takekoshi T, Ohta H, Ohashi I, et al. Four cases of mucous-secreting pancreatic cancer [in Japanese]. Progr Digest Endosc 1982; 20: 34851.
  • 2
    Furukawa T, Takahashi T, Kobari M, Matsuno S. The mucus-hypersecreting tumor of the pancreas—development and extension visualized by three-dimensional computerized mapping. Cancer 1992; 70: 150513.
  • 3
    Nishihara K, Fukuda T, Tsuneyoshi M, Kominami T, Maeda S, Saku M. Intraductal papillary neoplasm of the pancreas. Cancer 1993; 72: 68996.
  • 4
    Nagai E, Ueki T, Chijiiwa K, Tanaka M, Tsuneyoshi M. Intraductal papillary mucinous neoplasms of the pancreas associated with so-called “mucinous ductal ectasia”–histochemical and immunohistochemical analysis of 29 cases. Am J Surg Pathol 1995; 19: 57689.
  • 5
    Enrico S, Carlo C, Günter K. Tumor of the pancreas. Atlas of tumor pathology, third series, fascicle 20. Washington, DC: Armed Forces Institute of Pathology, 1997.
  • 6
    Yamaguchi K, Hirakawa R, Kitamura K. Mucinous cystic neoplasm of the pancreas. Estimation of grade of malignancy with imaging techniques and its surgical implications. Acta Chir Scand 1990;156: 55364.
  • 7
    Axeloson J, Andren-Sandberg A, Ihse I. Mucin-secreting pancreatic cancer, a review of diagnostic and therapeutic strategies. Scand J Gastroenterol 1993; 28: 4658.
  • 8
    Furukawa T, Tsukamoto Y, Naitoh Y, Mitake M, Hirooka Y, Hayakawa T. Differential diagnosis of pancreatic diseases with an intraductal ultrasound system. Gastrointest Endosc 1994; 40: 2139.
  • 9
    Obara T, Maguchi H, Saitoh Y, Itoh A, Arisato S, Ashida T, et al. Mucin-producing tumor of the pancreas: natural history and serial pancreatogram changes. Am J Gastroenterol 1993; 88: 5649.
  • 10
    Itoh S, Ishiguchi T, Sakuma S, Maruyama K, Senda K. Mucin-producing pancreatic tumor: CT findings and histopathologic correlation. Radiology 1992; 183: 816.
  • 11
    Uehara H, Nakaizumi A, Iishi H, Tatsuta M, Kitamura T, Okuda S, et al. Cytologic examination of pancreatic juice for differential diagnosis of benign and malignant mucin-producing tumors of the pancreas. Cancer 1994; 74: 82633.
  • 12
    Harley CB, Kim NW, Prowse KR, Weinrich SL, Horsch KS, West MD, et al. Telomerase, cell immortality, and cancer. Cold Spring Harbor Symp Quant Biol 1994; 59: 30715.
  • 13
    Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissue and cells. Dev Genet 1996; 18: 1739.
  • 14
    Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, et al. Specific association of human telomerase activity with immortal cells and cancer. Science (Washington DC) 1994; 266: 20115.
  • 15
    Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara E, et al. Telomerase activity in human liver tissue: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995; 55: 27346.
  • 16
    Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazder AF, et al. Telomerase activity in small cell and non-small-cell lung cancers. J Natl Cancer Inst 1995; 87: 895902.
  • 17
    Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, et al. Telomerase activity in gastric cancer. Cancer Res 1995; 55: 325862.
  • 18
    Venu RP, Geenen JE, Kini M, Hogan WJ, Payne M, Johnson K, et al. Endoscopic retrograde brush cytology: a new technique. Gastroentelorology 1990; 99: 14759.
  • 19
    Iwao T, Tsuchida A, Hanada K, Eguchi N, Kajiyama G, Shimamoto F, et al. Immunocytochemical detection of p53 protein as an adjunct in cytologic diagnosis from pancreatic duct brushings in mucin-producing tumor of the pancreas. Cancer 1997; 82: 16371.
  • 20
    Robins DB, Katz RL, Evans OB, Atkinson EN, Green L. Fine needle aspiration of the pancreas. In quest of accuracy. Acta Cytol 1995;39: 110.
  • 21
    Hiyama E, Kodama T, Shinbara K, Iwao T, Itoh M, Shay JW, et al. Telomerase activity is detected in pancreatic cancer but not benign tumors. Cancer Res 1997; 57: 32631.
  • 22
    Iwao T, Hiyama E, Yokoyama T, Tsuchida A, Hiyama K, Sasaki T, et al. Telomerase activity for the preoperative diagnosis of pancreatic cancer. J Natl Cancer Inst 1997; 89: 16213.
  • 23
    Wright WE, Shay JW, Piatyszek MA. Modification of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995; 23: 37945.
  • 24
    Zhang SY, Ruggeri B, Agarwal P, Sorling AF, Obara T, Ura H, et al. Immunohistochemical analysis of p53 expression in human pancreatic carcinomas. Arch Pathol Lab Med 1994; 118: 1504.
  • 25
    Hoshi T, Imai M, Ogawa K. Frequent K-ras mutations and absence of p53 mutations in mucin-producing tumors of the pancreas. J Surg Oncol 1994; 55: 8491.
  • 26
    Sessa F, Solcia E, Capella C, Bonato M, Scarpa A, Zamboni G, et al. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms; an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch 1994; 425: 35767.
  • 27
    Tada M, Ohahi M, Shiratori Y, Okudaira T, Komatsu Y, Kawabe Y, et al. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic diseases. Gastroenterology 1996; 110: 22731.
  • 28
    Uehara H, Akihiko N, Tatsuta M, Baba M, Takenaka A, Uedo N, et al. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutation. Gastroenterology 1999; 94: 25138.
  • 29
    Suehara N, Mizumoto K, Tanaka M, Niiyama H, Yokohata K, Tominaga Y, et al. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis. Clin Cancer Res 1997; 3: 247983.